Versant Capital Management Inc Has $83,000 Stake in Bath & Body Works, Inc. (NYSE:BBWI)

Versant Capital Management Inc lifted its holdings in shares of Bath & Body Works, Inc. (NYSE:BBWI) by 161.7% in the 4th quarter, HoldingsChannel.com reports. The fund owned 2,141 shares of the company’s stock after purchasing an additional 1,323 shares during the quarter. Versant Capital Management Inc’s holdings in Bath & Body Works were worth $83,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also made changes to their positions in BBWI. Lone Pine Capital LLC boosted its position in Bath & Body Works by 15.8% during the second quarter. Lone Pine Capital LLC now owns 11,315,515 shares of the company’s stock worth $441,871,000 after purchasing an additional 1,547,399 shares during the period. Anomaly Capital Management LP acquired a new stake in shares of Bath & Body Works during the 2nd quarter worth about $113,995,000. FMR LLC lifted its stake in shares of Bath & Body Works by 17,496.5% during the 3rd quarter. FMR LLC now owns 2,516,127 shares of the company’s stock worth $80,315,000 after buying an additional 2,501,828 shares during the last quarter. Sound Shore Management Inc. CT boosted its holdings in shares of Bath & Body Works by 10.0% during the 2nd quarter. Sound Shore Management Inc. CT now owns 2,088,703 shares of the company’s stock worth $81,564,000 after buying an additional 189,889 shares during the period. Finally, KBC Group NV grew its stake in Bath & Body Works by 9,023.5% in the 3rd quarter. KBC Group NV now owns 1,701,813 shares of the company’s stock valued at $54,322,000 after buying an additional 1,683,160 shares during the last quarter. 95.14% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other news, CEO Gina Boswell purchased 6,000 shares of the company’s stock in a transaction dated Wednesday, October 9th. The stock was bought at an average cost of $29.64 per share, for a total transaction of $177,840.00. Following the purchase, the chief executive officer now owns 242,987 shares of the company’s stock, valued at approximately $7,202,134.68. The trade was a 2.53 % increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 0.27% of the stock is currently owned by corporate insiders.

Bath & Body Works Price Performance

Shares of BBWI opened at $37.70 on Friday. The firm has a 50 day simple moving average of $34.96 and a two-hundred day simple moving average of $33.89. Bath & Body Works, Inc. has a one year low of $26.20 and a one year high of $52.99. The company has a market cap of $8.17 billion, a P/E ratio of 9.20, a P/E/G ratio of 1.43 and a beta of 1.83.

Bath & Body Works (NYSE:BBWI) last posted its quarterly earnings results on Monday, November 25th. The company reported $0.49 EPS for the quarter, topping analysts’ consensus estimates of $0.46 by $0.03. The company had revenue of $1.61 billion during the quarter, compared to analysts’ expectations of $1.58 billion. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. Bath & Body Works’s revenue was up 3.1% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.48 EPS. On average, analysts expect that Bath & Body Works, Inc. will post 3.26 earnings per share for the current fiscal year.

Bath & Body Works Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, December 6th. Stockholders of record on Friday, November 22nd were issued a $0.20 dividend. The ex-dividend date was Friday, November 22nd. This represents a $0.80 dividend on an annualized basis and a dividend yield of 2.12%. Bath & Body Works’s dividend payout ratio (DPR) is currently 19.51%.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on the stock. Barclays raised their price objective on shares of Bath & Body Works from $28.00 to $34.00 and gave the stock an “underweight” rating in a research report on Tuesday, November 26th. TD Cowen boosted their price target on Bath & Body Works from $42.00 to $48.00 and gave the company a “buy” rating in a research note on Thursday, December 12th. Piper Sandler increased their price objective on Bath & Body Works from $35.00 to $36.00 and gave the stock a “neutral” rating in a research report on Tuesday, November 26th. JPMorgan Chase & Co. boosted their target price on shares of Bath & Body Works from $35.00 to $39.00 and gave the company a “neutral” rating in a research report on Tuesday, November 26th. Finally, Telsey Advisory Group reaffirmed an “outperform” rating and set a $42.00 price target on shares of Bath & Body Works in a research report on Monday, November 25th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and nine have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $42.50.

About Bath & Body Works

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.